Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-01 @ 11:09 PM
Study NCT ID:
NCT06920004
Status:
RECRUITING
Last Update Posted:
2025-12-02
First Post:
2025-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-22
Start Date Type:
ACTUAL
Primary Completion Date:
2027-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-09
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-26
First Submit QC Date:
None
Study First Post Date:
2025-04-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-01
Last Update Post Date:
2025-12-02
Last Update Post Date Type:
ESTIMATED